Ibrutinib
- PDF / 181,662 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 2 Downloads / 191 Views
1
S
Fatal cerebral aspergillosis due to Aspergillus fumigatus infection: case report In a report of 43 patients under ibrutinib therapy, who were admitted to hospital in Spain due to suspect of infection between 2014 and 2018, a patient [age and sex not stated] was described, who developed fatal cerebral aspergillosis due to Aspergillus fumigatus infection during treatment with ibrutinib [route and dosage not stated] for unspecified cancer [exact indication and duration of treatment to reaction onset not stated]. Author comment: "[C]ases of Aspergillus fumigatus infection were identified, one of them causing a fatal cerebral aspergillosis." Cristina A-P, et al. Ibrutinib: Increased susceptibility to infections and use of resources associated. HemaSphere 3 (Suppl. 1): 866 abstr. PB1900, Jun 2019. Available from: URL: http://doi.org/10.1097/01.HS9.0000566104.46677.4f 803439246 [abstract] - Spain
0114-9954/19/1783-0001/$14.95 Adis © 2019 Springer Nature Switzerland AG. All rights reserved
Reactions 14 Dec 2019 No. 1783
Data Loading...
